Content area
Abstract
Funding
Merck, SARC, Sarcoma Foundation of America, QuadW Foundation, Pittsburgh Cure Sarcoma, and Ewan McGregor.
Details
Title
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
Author
Tawbi, Hussein A; Burgess, Melissa; Bolejack, Vanessa; van Tine, Brian A; Schuetze, Scott M; Hu, James; D'Angelo, Sandra; Attia, Steven; Riedel, Richard F; Priebat, Dennis A; Movva, Sujana; Davis, Lara E; Okuno, Scott H; Reed, Damon R; Crowley, John; Butterfield, Lisa H; Salazar, Ruth; Rodriguez-Canales, Jaime; Lazar, Alexander J; Wistuba, Ignacio I; Baker, Laurence H; Maki, Robert G; Reinke, Denise; Patel, Shreyaskumar
Pages
1493-1501
Section
Articles
Publication year
2017
Publication date
Nov 1, 2017
ISSN
14702045
e-ISSN
14745488
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
1959240772
Copyright
Copyright Elsevier Limited Nov 1, 2017